Home » Topics » Regulatory

Regulatory
RSS

FDA approves new indications, dosing regimens for Vantin

Dec. 2, 1998

Diane-35 now available in Canada for treatment of acne

Dec. 2, 1998

Unimed receives U.S. patent protection for dronabinol in treatment of dementia

Nov. 30, 1998

SSRI promising in the treatment of children and adolescents with OCD

Nov. 30, 1998

International study focuses on riluzole as a new approach to treating PD

Nov. 30, 1998

Immunex files sBLA for Enbrel as treatment for juvenile rheumatoid arthritis

Nov. 27, 1998

Zileuton trials recommended for new indication: atopic dermatitis

Nov. 27, 1998

Continued positive results with fexofenadine in patients with CIU

Nov. 27, 1998

New treatment option for pediatric HIV/AIDS now available in U.S.

Nov. 27, 1998

New study will assess troglitazone in the prevention of IGT

Nov. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...